News
BOSTON - Vertex Pharmaceuticals (NASDAQ: VRTX) shares tumbled 8.7% after the company announced its experimental pain drug VX-993 failed to meet the primary endpoint in a Phase 2 clinical trial, ...
Carronade Capital has been advocating for the separation of Viasat’s Defense and Advanced Technologies segment, arguing it could be one of the most attractive pure-play defense technology platforms in ...
Investing.com -- India’s Nifty index could touch fresh highs in the coming months, says Morgan Stanley, saying that a ...
Investing.com -- Israeli Prime Minister Benjamin Netanyahu is considering expanding military operations in Gaza to seize the entire enclave, according to an official from his office cited by Israel’s ...
Investing.com -- U.S. President Donald Trump announced Monday he plans to "substantially" raise tariffs on India, citing the country’s purchases and sales of Russian oil amid the ongoing conflict in ...
Investing.com -- Stifel downgraded Baxter International (NYSE: BAX) to Hold from Buy and slashed its price target to $25 from $36, citing a weaker-than-expected second quarter and a longer timeline ...
Investing.com -- The United States will implement a pilot program requiring bonds of up to $15,000 for certain tourist and business visa applicants, according to a U.S. government notice released ...
Investing.com -- Equillium Inc (NASDAQ: EQ) stock tumbled 12.4% after the biotechnology company announced plans to integrate cryptocurrency into its treasury reserve strategy, a significant deviation ...
Switzerland says it continues to negotiate with U.S. Investing.com -- The Swiss government announced Monday it will continue negotiations with the United States regarding tariffs after experts warned ...
Given that the labor market and economy are truly showing signs of weakening and tariffs are not overly impacting inflation, it seems Trump has a case. That said, it may be a few more months before ...
Evercore lays out two scenarios. In a benign case, only a few changes occur, leading to a Fed led by a Trump-appointed chair but operating within existing norms. In this version, monetary policy would ...
"We are extremely pleased with our outstanding results in the second quarter," said Chuck Treadway, President and Chief Executive Officer. "CommScope net sales of $1.39 billion increased 31.7% from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results